Clinical trial
Schizotypal Personality Disorder Risperidone
NCT02535156 is registered in ClinicalTrials.gov with Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Schizotypal Personality Disorder Risperidone
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- January 31, 2015
- Enrollment
- 21 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.